TC Biopharm (Holdings) Plc Sponsored ADR (TCBP) has released an update.
TC BioPharm (Holdings) PLC successfully conducted its 2024 Annual General Meeting with all proposed resolutions passing by shareholder vote. Key resolutions included the approval of the annual report and audited financial statements for 2023, the appointment and remuneration of auditors, and the directors’ remuneration report. Full details of the resolutions were previously provided to shareholders and filed with the U.S. SEC.
For further insights into TCBP stock, check out TipRanks’ Stock Analysis page.
